Glaxo, Atlas syndicate bankrolls Spero’s drive into the clinic with $30M round Posted on February 2, 2016 at 12:45 am.Written by Spero Therapeutics Post navigation Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant BugsThe Potentiator: Spero Therapeutics gets $30M to up potency of existing antibiotics
